Related Experiment Video
Updated: Sep 19, 2025
Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
MicroRNAs in cardiac arrhythmias: Mechanisms, biomarkers, and therapeutic frontiers
Apurva Popat1, Geethu Jnaneswaran1, Srinivasulu Yerukala Sathipati2
1Department of Internal Medicine, Marshfield Clinic Health System, Marshfield, Wisconsin.
Abstract:
MicroRNAs (miRNAs) are essential modulators of cardiac arrhythmias, influencing electrical remodeling, ion channel dynamics, and fibrosis. Dysregulated miRNAs, including miR-1, miR-21, and miR-328, contribute to arrhythmogenesis through altered ion channel expression, heightened fibrosis, and inflammation. Recent investigations have identified novel circulating miRNA signatures, such as hsa-miR-96-5p and hsa-miR-184, for postoperative atrial fibrillation after coronary artery bypass grafting, offering high predictive accuracy and targeting pathways such as mitogen-activated protein kinase and transforming growth factor beta, as revealed by biological pathway analysis. These miRNAs serve as noninvasive biomarkers for early risk assessment. Therapeutically, miRNA inhibitors and mimics, enhanced by nanoparticle and viral vector delivery, provide targeted interventions. Despite challenges in specificity and delivery, miRNA-based approaches hold transformative potential for arrhythmia diagnosis and personalized management.
Insights
MicroRNAs (miRNAs) are key regulators of cardiac arrhythmias. Novel circulating miRNA signatures show promise as noninvasive biomarkers for early risk assessment and personalized treatment of heart rhythm disorders.
Area of Science:
- Cardiology
- Molecular Biology
- Biomarkers
Background:
- MicroRNAs (miRNAs) are critical regulators of cardiac function, impacting electrical remodeling, ion channel activity, and fibrosis.
- Dysregulation of specific miRNAs (e.g., miR-1, miR-21, miR-328) is implicated in the development of cardiac arrhythmias (arrhythmogenesis).
Purpose of the Study:
- To explore the role of circulating miRNAs as biomarkers for cardiac arrhythmias, specifically postoperative atrial fibrillation.
- To identify novel miRNA signatures for early risk assessment and potential therapeutic targets in cardiovascular disease.
Main Methods:
- Analysis of circulating miRNA signatures, including hsa-miR-96-5p and hsa-miR-184, in patients undergoing coronary artery bypass grafting.
- Biological pathway analysis to identify targeted signaling pathways (e.g., MAPK, TGF-β).
- Review of miRNA-based therapeutic strategies, including inhibitors and mimics with advanced delivery systems.
Main Results:
- Novel circulating miRNA signatures (hsa-miR-96-5p, hsa-miR-184) demonstrate high predictive accuracy for postoperative atrial fibrillation.
- Identified miRNAs target key pathways involved in cardiac remodeling and inflammation.
- These miRNAs function as noninvasive biomarkers for early detection and risk stratification.
Conclusions:
- Circulating miRNAs represent promising noninvasive biomarkers for the early assessment and management of cardiac arrhythmias.
- miRNA-based diagnostics and therapeutics offer transformative potential for personalized cardiovascular medicine.
- Further research into miRNA delivery and specificity is crucial for clinical translation.
More Related Videos
Related Concept Videos
01:28Mechanism of Cardiac Arrhythmias
01:30Dysrhythmias V: Evaluating Dysrhythmias
01:25Dysrhythmias VI: Management of Dysrhythmias
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:16ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...